Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cryo Cell International (CCEL) Cash & Current Investments (2016 - 2025)

Historic Cash & Current Investments for Cryo Cell International (CCEL) over the last 16 years, with Q3 2025 value amounting to $3.2 million.

  • Cryo Cell International's Cash & Current Investments rose 5146.23% to $3.2 million in Q3 2025 from the same period last year, while for Aug 2025 it was $3.2 million, marking a year-over-year increase of 5146.23%. This contributed to the annual value of $3.5 million for FY2024, which is 25665.83% up from last year.
  • Cryo Cell International's Cash & Current Investments amounted to $3.2 million in Q3 2025, which was up 5146.23% from $4.4 million recorded in Q2 2025.
  • In the past 5 years, Cryo Cell International's Cash & Current Investments ranged from a high of $11.4 million in Q1 2021 and a low of $713916.0 during Q4 2022
  • Moreover, its 5-year median value for Cash & Current Investments was $2.9 million (2022), whereas its average is $3.7 million.
  • Per our database at Business Quant, Cryo Cell International's Cash & Current Investments tumbled by 9143.83% in 2022 and then skyrocketed by 25665.83% in 2024.
  • Quarter analysis of 5 years shows Cryo Cell International's Cash & Current Investments stood at $8.3 million in 2021, then plummeted by 91.44% to $713916.0 in 2022, then skyrocketed by 37.31% to $980250.0 in 2023, then surged by 256.66% to $3.5 million in 2024, then dropped by 7.86% to $3.2 million in 2025.
  • Its Cash & Current Investments was $3.2 million in Q3 2025, compared to $4.4 million in Q2 2025 and $3.5 million in Q1 2025.